Skip to content
healthcare.dev

Dexrazoxane

NDC 72266-235, Dexrazoxane for Injection, injection, powder, lyophilized, for solution, from Fosun Pharma USA Inc..

Product NDC
72266-235
Status
Listed
Labeler
Fosun Pharma USA Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207321
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72266-235 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEXRAZOXANE HYDROCHLORIDE250 mg/25mL

Pharmacologic classes

Cytoprotective Agent [EPC]

Package NDCNDC-11Package
72266-235-01722660235011 VIAL in 1 CARTON (72266-235-01) / 25 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c1d98fbe-5fd9-4518-b1a5-fac92e32928f
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=72266-235

Use it

Look up 72266-235 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72266-235 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72266-235. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.